NO981078L - Faste blandinger av cyklodekstriner fremstilt via smelteekstrusjon - Google Patents

Faste blandinger av cyklodekstriner fremstilt via smelteekstrusjon

Info

Publication number
NO981078L
NO981078L NO981078A NO981078A NO981078L NO 981078 L NO981078 L NO 981078L NO 981078 A NO981078 A NO 981078A NO 981078 A NO981078 A NO 981078A NO 981078 L NO981078 L NO 981078L
Authority
NO
Norway
Prior art keywords
melt extrusion
prepared via
solid mixtures
via melt
cyclodextrins prepared
Prior art date
Application number
NO981078A
Other languages
English (en)
Norwegian (no)
Other versions
NO981078D0 (no
Inventor
Lieven Elvire Colette Baert
Jozef Peeters
Geert Verreck
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26139823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO981078(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO981078D0 publication Critical patent/NO981078D0/no
Publication of NO981078L publication Critical patent/NO981078L/no

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO981078A 1995-11-23 1998-03-11 Faste blandinger av cyklodekstriner fremstilt via smelteekstrusjon NO981078L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP95203219 1995-11-23
PCT/EP1996/005118 WO1997018839A1 (en) 1995-11-23 1996-11-20 Solid mixtures of cyclodextrins prepared via melt-extrusion
US09/081,808 US6365188B1 (en) 1995-11-23 1998-05-20 Solid mixtures of cyclodextrins prepared via meltextrusion

Publications (2)

Publication Number Publication Date
NO981078D0 NO981078D0 (no) 1998-03-11
NO981078L true NO981078L (no) 1998-05-22

Family

ID=26139823

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981078A NO981078L (no) 1995-11-23 1998-03-11 Faste blandinger av cyklodekstriner fremstilt via smelteekstrusjon

Country Status (16)

Country Link
US (1) US6365188B1 (pl)
EP (1) EP0862463A1 (pl)
JP (1) JP3310299B2 (pl)
CN (1) CN1198655C (pl)
AU (1) AU725204B2 (pl)
BR (1) BR9611562A (pl)
CZ (1) CZ154398A3 (pl)
HU (1) HUP9900730A3 (pl)
IL (1) IL123654A (pl)
NO (1) NO981078L (pl)
NZ (1) NZ322907A (pl)
PL (1) PL189122B1 (pl)
SK (1) SK67298A3 (pl)
TR (1) TR199800729T2 (pl)
WO (1) WO1997018839A1 (pl)
ZA (1) ZA969831B (pl)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ322907A (en) * 1995-11-23 1998-12-23 Janssen Pharmaceutica Nv Solid mixtures of cyclodextrins prepared via melt-extrusion
KR19990001564A (ko) * 1997-06-16 1999-01-15 유충식 용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제
ES2174538T3 (es) 1997-11-28 2002-11-01 Knoll Ag Procedimiento para la obtencion de substancias exentas de disolventes, no cristalinas, biologicamente activas.
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
HU230394B1 (hu) 1998-11-10 2016-04-28 Janssen Pharmaceutica N.V. HIV-vírus szaporodását gátló pirimidin-származékok
US6194395B1 (en) 1999-02-25 2001-02-27 Orthro-Mcneil Pharmaceutical, Inc. Cyclodextrin cladribine formulations
DE19911097A1 (de) * 1999-03-12 2000-09-14 Basf Ag Verfahren zur Herstellung von festen cyclodextrinhaltigen Dosierungsformen
DK1163234T3 (da) 1999-03-24 2006-02-27 Scherer Technologies Inc R P Farmaceutiske formuleringer med forbedret vandoplöselighed
CA2372691C (en) 1999-05-04 2009-11-17 Janssen Pharmaceutica N.V. Antifungal ethers
FR2803748A1 (fr) * 2000-01-14 2001-07-20 Ethypharm Lab Prod Ethiques Composition d'itraconazole et procede de preparation
WO2001064674A1 (en) 2000-03-01 2001-09-07 Janssen Pharmaceutica N.V. 2,4-disubstituted thiazolyl derivatives
US6835717B2 (en) * 2000-03-08 2004-12-28 The Johns Hopkins University School Of Medicine β-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases
EP1282606B1 (en) 2000-05-08 2015-04-22 Janssen Pharmaceutica NV Hiv replication inhibiting pyrimidines and triazines
ITRN20000051A1 (it) 2000-12-22 2002-06-22 Ascor Chimici Srl Metodo e apparecchiatura per formare sferule composite contenenti principi attivi del tipo farmaceutico e/o integratori alimentari o cosmeti
GB0113841D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
IL160329A0 (en) 2001-08-13 2004-07-25 Janssen Pharmaceutica Nv 2-amino-4,5-trisubstituted thiazolyl derivatives
US7638522B2 (en) 2001-08-13 2009-12-29 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
US8101629B2 (en) 2001-08-13 2012-01-24 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
MXPA04007776A (es) 2002-03-13 2004-10-15 Janssen Pharmaceutica Nv Derivados de sulfonilamino como nuevos inhibidores de histona deacetilasa.
EA007272B1 (ru) 2002-03-13 2006-08-25 Янссен Фармацевтика Н. В. Новые ингибиторы гистондеацетилазы
CN102702111B (zh) 2002-08-09 2014-12-17 詹森药业有限公司 制备4-[[4-[[4-(2-氰基乙烯基)-2,6-二甲基苯基]氨基]-2-嘧啶基]氨基]苄腈的方法
EP1597242B1 (en) 2003-02-07 2008-07-23 Janssen Pharmaceutica N.V. Hiv inhibiting 1,2,4-triazines
MXPA05008364A (es) 2003-02-07 2005-11-04 Janssen Pharmaceutica Nv Derivados de pirimidina para la prevencion de una infeccion por vih.
CL2004000306A1 (es) 2003-02-20 2005-04-08 Tibotec Pharm Ltd Compuestos derivados de pirimidina sustituidas con indano; proceso para su preparacion; composicion farmaceutica que lo comprende; combinacion farmaceutica; y su uso para el tratamiento o profilaxis de una enfermedad infecciosa.
SG175450A1 (en) * 2003-03-28 2011-11-28 Ares Trading Sa Oral formulations of cladribine
EA009714B1 (ru) 2003-03-28 2008-02-28 Арес Трейдинг С.А. Препараты кладрибина для улучшенной пероральной доставки и доставки через слизистые оболочки
EP1668011B1 (en) 2003-09-25 2011-03-02 Janssen Pharmaceutica NV Hiv replication inhibiting purine derivatives
US20050118265A1 (en) * 2003-11-28 2005-06-02 Anandi Krishnan Antifungal oral dosage forms and the methods for preparation
SG156687A1 (en) 2004-07-28 2009-11-26 Janssen Pharmaceutica Nv Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
CN101035773B (zh) 2004-08-10 2012-06-06 詹森药业有限公司 抑制hiv的1,2,4-三嗪-6-酮衍生物
MX2007003796A (es) 2004-09-30 2007-04-25 Tibotec Pharm Ltd Pirimidinas 5-sustituidas inhibidoras del virus de inmunodeficiencia humana.
CA2577467C (en) 2004-09-30 2013-05-28 Tibotec Pharmaceuticals Ltd. Hiv inhibiting 5-heterocyclyl pyrimidines
CN101048410B (zh) 2004-10-29 2010-06-23 泰博特克药品有限公司 抑制hiv的双环嘧啶衍生物
CN101107234B (zh) 2005-01-27 2013-06-19 泰博特克药品有限公司 抑制hiv的2-(4-氰基苯氨基)嘧啶衍生物
AU2006222057B2 (en) 2005-03-04 2012-10-04 Janssen Sciences Ireland Uc HIV inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines
CA2618264C (en) * 2005-08-08 2015-11-24 Abbott Gmbh & Co. Kg Dosage forms with improved bioavailability
WO2007047253A2 (en) * 2005-10-11 2007-04-26 Eastman Chemical Company Pharmaceutical formulations of cyclodextrins and antifungal azole compounds
JP5247470B2 (ja) 2006-01-19 2013-07-24 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ヒストンデアセチラーゼのインヒビターとしてのピリジン及びピリミジン誘導体
EP1832281A1 (en) * 2006-03-10 2007-09-12 Abbott GmbH & Co. KG Process for producing a solid dispersion of an active ingredient
RU2480464C2 (ru) 2006-03-30 2013-04-27 Тиботек Фармасьютикалз Лтд. 5-амидо-замещенные пиримидины, ингибирующие вич
EP2004641B1 (en) 2006-03-30 2010-09-29 Tibotec Pharmaceuticals Hiv inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines
JP5185283B2 (ja) 2006-12-29 2013-04-17 テイボテク・フアーマシユーチカルズ Ｈｉｖ阻害６−置換ピリミジン
BRPI0722079B8 (pt) 2006-12-29 2021-05-25 Janssen R & D Ireland pirimidinas 5,6-substituídas inibidoras de hiv e composição farmacêutica que as compreende
WO2009134848A1 (en) * 2008-04-30 2009-11-05 Novartis Ag Continuous process for making pharmaceutical compositions
JP2012525895A (ja) 2009-05-07 2012-10-25 ジーイーエイ・ファーマ・システムズ・リミテッド 錠剤の製造モジュール及び錠剤の連続製造方法
US20120148678A1 (en) 2010-12-08 2012-06-14 Advanced Technologies And Regenerative Medicine, Llc. Sustained release of poorly water soluble active compounds
US10532102B2 (en) 2016-08-19 2020-01-14 Foresee Pharmaceuticals Co., Ltd. Pharmaceutical composition and methods of uses
CN107441504A (zh) * 2017-09-06 2017-12-08 广州中医药大学 番茄红素包合物及其制备方法及番茄红素包合物片剂、胶囊和颗粒
CN110898015A (zh) * 2019-12-31 2020-03-24 上海汉维生物医药科技有限公司 一种伊曲康唑制剂的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61152765A (ja) * 1984-12-27 1986-07-11 Nippon Ekishiyou Kk シクロデキストリン類で包接された化合物を含有した合成樹脂製品及びその製造方法
US5009900A (en) * 1989-10-02 1991-04-23 Nabisco Brands, Inc. Glassy matrices containing volatile and/or labile components, and processes for preparation and use thereof
DE69327877T2 (de) * 1992-10-14 2000-10-05 Nippon Shinyaku Co Ltd Verfahren zur verschiebung eines kristallzustandes
WO1994011031A1 (en) * 1992-11-10 1994-05-26 Nippon Shinyaku Co., Ltd. Enclosure compound manufacturing method
FR2705677B1 (fr) * 1993-05-28 1995-08-11 Roquette Freres Micro-granules obtenus par extrusion-sphéronisation contenant une cyclodextrine.
NZ322907A (en) * 1995-11-23 1998-12-23 Janssen Pharmaceutica Nv Solid mixtures of cyclodextrins prepared via melt-extrusion
KR100331529B1 (ko) 1999-06-16 2002-04-06 민경윤 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법

Also Published As

Publication number Publication date
AU7694396A (en) 1997-06-11
HUP9900730A2 (hu) 1999-07-28
CN1198655C (zh) 2005-04-27
US6365188B1 (en) 2002-04-02
AU725204B2 (en) 2000-10-05
PL189122B1 (pl) 2005-06-30
CZ154398A3 (cs) 1998-08-12
BR9611562A (pt) 1999-03-02
TR199800729T2 (xx) 1998-07-21
EP0862463A1 (en) 1998-09-09
IL123654A0 (en) 1998-10-30
WO1997018839A1 (en) 1997-05-29
SK67298A3 (en) 1998-11-04
CN1200677A (zh) 1998-12-02
HUP9900730A3 (en) 2001-04-28
JP3310299B2 (ja) 2002-08-05
JPH11501050A (ja) 1999-01-26
NO981078D0 (no) 1998-03-11
NZ322907A (en) 1998-12-23
ZA969831B (en) 1998-05-22
IL123654A (en) 2001-08-08
PL326161A1 (en) 1998-08-31

Similar Documents

Publication Publication Date Title
NO981078L (no) Faste blandinger av cyklodekstriner fremstilt via smelteekstrusjon
HUP9903384A3 (en) Solid medicaments obtained by extrusion of an isomalt-containing polymer-active substance melt
BR9606733A (pt) Produção de artigos extrudados
DE69621410D1 (de) Stabilisierte thermoplastische Polymerzusammensetzung
PT918892E (pt) Fabrico de artigos extrudidos
NO962603D0 (no) Stabilisert PVC-blanding for fremstilling av formlegemer
GB9514762D0 (en) An assembly of two extruded members
NO964685L (no) Isomering av equilin
FI956030A0 (fi) Anordning foer extrudering av plastroer
NO962371D0 (no) Stabilisering av polymerer
KR970000923U (ko) 차량의 백글라스 몰딩구조
KR970039894U (ko) 도어의 플라스틱 문틀
KR970012581U (ko) 차량의 모울딩구조
KR960028572U (ko) 도어섀시의 몰딩재 취부구조
KR970021520U (ko) 자동차 도어 프레임의 몰딩 결합구조
KR970038313U (ko) 화물 자동차의 리어 스텝 구조
KR970005608U (ko) 화물자동차의 후부도어 구조
NO951859D0 (no) Utforming av tunnelåpning
FI950412A0 (fi) Foerfarande och anordning foer effektivisering av en soenderslagningsanordning funktion
KR970001253U (ko) 버스의 모울딩 인너
KR970029337U (ko) 차량용 도어의 밀폐구조
KR960033922U (ko) 도어 몰딩의 앤드 캡 구조
FI955217A0 (fi) Foerfarande foer framstaellning av braensle av slam
KR970032447U (ko) 화물자동차의 적재함 구조
KR970013517U (ko) 화물차량의 테일 게이트

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application